AdvanSix Inc (ASIX)

Return on equity (ROE)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	44,149	38,715	8,472	2,273	54,623	93,329	111,338	143,767	171,886	161,849	195,759	174,733	139,791	142,968	98,334	65,632	46,077	17,219	25,832	29,749
Total stockholders’ equity	US$ in thousands	774,650	766,408	746,597	713,157	739,237	754,485	774,359	758,067	738,180	714,277	719,209	658,391	601,190	566,311	522,829	474,588	444,123	421,034	420,787	407,836
ROE		5.70%	5.05%	1.13%	0.32%	7.39%	12.37%	14.38%	18.96%	23.29%	22.66%	27.22%	26.54%	23.25%	25.25%	18.81%	13.83%	10.37%	4.09%	6.14%	7.29%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $44,149K ÷ $774,650K
= 5.70%

AdvanSix Inc's return on equity (ROE) has fluctuated over the past few years, reflecting changes in the company's financial performance. The ROE was relatively low in the earlier periods, ranging from around 4% to 10%. However, there was a notable improvement in ROE starting from the first quarter of 2021, with a significant increase to 13.83% and reaching a peak of 27.22% in the second quarter of 2022.

Subsequently, the ROE showed some variability but generally remained at elevated levels above 20% until the third quarter of 2022. From then on, there was a noticeable decline in the ROE, dropping to around 12% by the end of 2023. The downward trend continued into 2024, with the ROE falling to as low as 0.32% in the first quarter before gradually recovering to 5.70% by the end of the year.

Overall, although AdvanSix Inc experienced periods of strong profitability as indicated by high ROE figures, there were also phases of decreased profitability and volatility in performance. It is important for investors and stakeholders to closely monitor the company's ROE trend to assess its financial health and sustainability in generating returns for shareholders.